Fundz
Free weekly newsletter

Get the free weekly contract digest

The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New new contracts, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Contract Trends

See who's moving and how much in your market

No credit card required Weekly contract digest

Diag-Nose.io Opens Houston Office following $2M Seed Round

Jan 30, 2025•over 1 year ago

Contract Type

partnership

BethlehemBiotechnologyHealth CareArtificial IntelligenceTherapeuticsHealth Diagnostics

Description

Diag-Nose.io has opened a new office in Houston, Texas, following the successful completion of its oversubscribed $2 million seed round. The fundraise marks a significant step forward in the company's mission to transform respiratory care using advanced proteomics and artificial intelligence.

Company Information

Company

Diag-Nose.io

Location

Bethlehem, Pennsylvania, United States

About

Diag-Nose.io is a biotechnology company founded in 2020, focusing on precision diagnostic and drug discovery solutions for chronic respiratory diseases. Their technology integrates advanced proteomics, computational biology, and AI to enhance treatment prescription and accelerate new therapy development. The flagship platform, RhinoMAP™, aims to predict respiratory disease activity and monitor treatment efficacy. Diag-Nose.io's innovative approach seeks to transform respiratory healthcare through data-driven personalized care.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Diag-Nose.io's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.